XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net loss $ (20,742) $ (11,592)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 45,127 41,997
Stock-based compensation expense 10,070 8,004
Excess tax benefits from stock-based compensation (1,132) (1,654)
Deferred taxes 4,398 (14,080)
Asset impairment charges 195 319
Change in fair value of 1.25% call option and cash conversion option 56 0
Other losses (gains), net 1,407 (8,575)
Changes in operating assets and liabilities, net of business combinations:    
Accounts receivable, net (28,178) (10,905)
Prepaid expenses and other assets 2,363 (12,832)
Accounts payable (889) 21,735
Accrued expenses (14,255) (7,616)
Accrued compensation and benefits (27,027) 849
Deferred revenue 54,248 35,462
Other liabilities (4,353) (1,746)
Net cash provided by operating activities 21,288 39,366
Cash flows from investing activities:    
Capital expenditures (11,945) (16,435)
Capitalized software (9,144) (7,871)
Cash paid for business acquisitions, net of cash acquired 0 (148,802)
Purchases of marketable securities, other investments and related intangible assets (5,968) 0
Sales and maturities of other investments 19 12,516
Proceeds from sale of fixed assets 55 0
Net cash used in investing activities (26,983) (160,592)
Cash flows from financing activities:    
Proceeds from issuance of common stock 1,673 7,931
Excess tax benefits from stock-based compensation 1,132 1,654
Taxes paid related to net share settlement of equity awards (3,184) (1,648)
Payments of capital lease obligations (110) (182)
Credit facility payments (30,313) (27,614)
Credit facility borrowings, net of issuance costs 15,000 129,043
Net cash (used in) provided by financing activities (15,802) 109,184
Effect of exchange rate changes on cash and cash equivalents 123 314
Net decrease in cash and cash equivalents (21,374) (11,728)
Cash and cash equivalents, beginning of period 62,954 103,956
Cash and cash equivalents, end of period $ 41,580 $ 92,228